These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2621033)

  • 1. Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts.
    Krantz I; Taranger J; Trollfors B
    Int J Epidemiol; 1989 Dec; 18(4):959-63. PubMed ID: 2621033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How common is whooping cough in a nonvaccinating country?
    Isacson J; Trollfors B; Taranger J; Zackrisson G; Lagergård T
    Pediatr Infect Dis J; 1993 Apr; 12(4):284-8. PubMed ID: 8483621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P
    Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress in the prevention and control of whooping cough].
    Zuo W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):309-10. PubMed ID: 15468509
    [No Abstract]   [Full Text] [Related]  

  • 6. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
    Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
    N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The wandering myths about vaccination against whooping cough].
    Rabo E
    Lakartidningen; 1999 Sep; 96(37):3881. PubMed ID: 10522092
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of pertussis vaccine efficacy in the presence of covariates in three randomized trials.
    Blackwelder WC; VanRaden MJ; Deloria MA
    Dev Biol Stand; 1997; 89():161-6. PubMed ID: 9272346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
    Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
    J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Whooping cough epidemiology in Denmark prior to and after the introduction of whooping cough vaccination. Protective effect of the vaccine and herd immunity].
    Nielsen A; Larsen SO
    Ugeskr Laeger; 1990 Feb; 152(9):597-604. PubMed ID: 2309370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of a pertussis vaccination programme for Japan considering intergenerational infection.
    Itatani T; Shimizu S; Iwasa M; Ohkusa Y; Hayakawa K
    Vaccine; 2013 Jun; 31(27):2891-7. PubMed ID: 23570987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. As immunity wanes, whooping cough returns.
    Chin TL
    Health Aff (Millwood); 2014 Dec; 33(12):2095-8. PubMed ID: 25489026
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Gill CJ; Mwananyanda L; MacLeod W; Kwenda G; Mwale M; Williams AL; Siazeele K; Yang Z; Mwansa J; Thea DM
    Clin Infect Dis; 2016 Dec; 63(suppl 4):S154-S164. PubMed ID: 27838668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diphtheria--tetanus--pertussis].
    Gasparini R; Marensi L; Basso G
    Pediatr Med Chir; 1994; 16(4):377-85. PubMed ID: 7816702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Whooping cough--not eradicated, but forgotten].
    Swidsinski S; Schlesinger FL; Mebel S
    Z Arztl Fortbild (Jena); 1989; 83(6):309-12. PubMed ID: 2660433
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia.
    Carcione D; Regan AK; Tracey L; Mak DB; Gibbs R; Dowse GK; Bulsara M; Effler PV
    Vaccine; 2015 Oct; 33(42):5654-5661. PubMed ID: 26320420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.